VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $235,046 | -39.4% | 31,806 | -18.9% | 0.01% | -41.2% |
| Q3 2022 | $388,000 | -9.8% | 39,225 | -0.6% | 0.02% | -5.6% |
| Q2 2022 | $430,000 | -1.1% | 39,454 | +2.6% | 0.02% | 0.0% |
| Q1 2022 | $435,000 | -33.4% | 38,438 | -7.7% | 0.02% | -21.7% |
| Q4 2021 | $653,000 | -31.0% | 41,638 | -24.6% | 0.02% | -32.4% |
| Q3 2021 | $946,000 | -23.0% | 55,206 | -3.3% | 0.03% | -17.1% |
| Q2 2021 | $1,228,000 | +47.6% | 57,086 | +3.0% | 0.04% | +57.7% |
| Q1 2021 | $832,000 | +11.4% | 55,408 | -2.6% | 0.03% | +4.0% |
| Q4 2020 | $747,000 | – | 56,875 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |